查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1496016

眼科超音波系統的全球市場 - 2024 年至 2029 年預測

Global Ophthalmic Ultrasound Systems Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 124 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

眼科超音波系統市場預計將從 2022 年的 27 億美元增加到 2029 年的 46.7 億美元，預測期內複合年成長率為 8.16%。

眼科超音波系統是眼科中用於診斷影像和治療目的的專用醫療設備。這些系統利用高頻聲波創建眼睛內部結構的詳細影像，包括角膜、水晶體、玻璃體和視網膜。當光同調斷層掃瞄(OCT) 和眼底攝影等傳統影像技術無法充分顯示眼睛的內側混濁或後段時，眼科超音波特別有用。

眼科超音波可以幫助診斷和治療多種眼科疾病，包括視網膜剝離、眼內腫瘤、玻璃體出血和青光眼。此外，超音波顯微鏡 (UBM) 是眼科超音波的一種特殊形式，用於對虹膜、睫狀體和眼角等眼前節結構進行高解析度成像。眼科超音波系統在眼科疾病的綜合評估和治療中發揮重要作用，有助於改善眼科實踐中的患者照護和治療結果。

市場促進因素：

光學疾病的增加預計將推動眼科超音波系統市場的成長。

近視、遠視、散光和老花眼等光學疾病在全球範圍內不斷增加，預計將在估計期內推動眼科超音波系統市場的擴張。例如，根據世界衛生組織（WHO）2021年10月的資料，全球整體約有22億人患有近視和遠視疾病，其中約10億病例是可以預防或治療的。

此外，世界衛生組織估計，全世界約有 8.26 億人受到未經治療的老花眼的影響。屈光不正、老齡化黃斑部病變、白內障和青光眼被認為是世界範圍內視力障礙和視力障礙的主要原因，視力喪失影響著各個年齡段的人，尤其是50多歲的人。這些發現突顯了全球眼科疾病負擔日益加重，推動了對眼科超音波設備市場的需求，這對於診斷此類疾病至關重要。

糖尿病視網膜病變的日益普及預計將增加對眼科超音波系統的需求。

糖尿病視網膜病變的盛行率是未來市場擴張的關鍵因素之一。例如，根據美國眼科學會的最新資料，2016年全球約有3.87億糖尿病患者，預計2035年將增加至5.92億。

此外，糖尿病視網膜病變影響全球約 9,300 萬人。 1 型糖尿病患者糖尿病視網膜病變的盛行率為 77.3%，2 型糖尿病患者糖尿病視網膜病變的盛行率為 25.1%。據估計，25-30% 的第 2 型糖尿病患者會出現威脅視力的糖尿病黃斑部水腫。 5-8% 的糖尿病視網膜病變患者需要雷射治療。

預計北美將佔據大部分市場。

意識的提高、可支配收入的增加、老年人口的新興市場以及眼科疾病的流行等變數正在導致北美市場的擴張。多篇研究報導強調了視覺障礙和其他視覺障礙的優點。

例如，在美國，大約有 1,200 萬 40 歲以上的成年人患有無法矯正的視力障礙，其中超過 100 萬人被歸類為盲人。由於糖尿病和其他慢性病的增加以及美國老年人口的不斷增加，預計到 2050 年，盲人人數將飆升至 896 萬人。此外，美國疾病管制與預防美國(CDC) 報告稱，大約 3% 的 18 歲以下兒童患有視力障礙或失明。

未確診疾病數量的增加預計將進一步促進市場擴張。

此外，安大略省驗光師協會 2021 年 7 月的一篇報導描述了加拿大人口老化對矯正視力優勢的影響。報告稱，有 120 萬加拿大人視力喪失，其中光是安大略省居住466,000 人。

此外，超過 800 萬加拿大人（安大略省約 310 萬）患有四種基本眼疾之一：老齡化黃斑部病變、青光眼、糖尿病視網膜病變和白內障，可能患有或目前患有視力喪失。眼科疾病領域日益成長的主導地位預計將提高眼科超音波系統的市場佔有率，從而推動該行業的擴張。

市場開拓：

  • 2024 年 4 月 - 華平投資收購印度最大的眼科設備和人工水晶體製造商 Appasamy Associates 的股份。這是該公司在印度醫療保健領域最大的投資。 Apathamy 強大的研發能力和垂直整合使我們能夠以實惠的價格提供產品。
  • 2023 年 2 月 - 日本電產推出 Cube a 眼科手術系統，這是一種新型超音波技術，可提高超音波乳化和手術的安全性。該系統採用陀螺扭轉技術設計，是眼科手術設備系列的一個有價值的補充，因為它可以有效地提供超音波能量並保護眼內組織，特別是對於中度白內障。
  • 2022 年 10 月－豪邁以約 1.38 億歐元（相當於 1.45 億美元）收購 IZI Medical Product。
  • 2022 年 3 月 - Lumibird Medical 在孟買成立子公司 Lumibird Medical India，以加強 Quantel Medical 和 Elex 產品在印度的銷售。該子公司旨在共用超音波平台、眼科雷射以及乾眼診斷和治療設備。

公司產品

  • 平台超音波診斷設備超音波診斷設備它提供多重模式影像，可用於婦產科、循環系統、MSK、重症加護、急診醫學、麻醉和小兒科各個領域。它提供多種成像模式，包括黑白、彩色多普勒、3D/4D、頻譜多普勒、彈性成像和針頭引導。
  • Ezer 超音波 A/B 掃描儀 EUS-2600 -美國眼科的 Ezer EUS-2600超音波A/B 掃描儀具有多種 TGC 選項、即時影像/視訊擷取、大型 12.1 吋 LCD 觸控螢幕顯示器和使用者友好的臨床功能報告、自動AL 採集、PDF 報告、HDMI 和DICOM 3.0通訊協定等介面以及可容納 20,000 多個測試的大儲存容量。它還具有高清 20MHz B 掃描探頭和 Dist-5 浸沒法。

目錄

第1章簡介

  • 市場概況
  • 市場定義
  • 調查範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關利益者的主要利益

第2章調查方法

  • 研究設計
  • 調查過程

第3章執行摘要

  • 主要發現

第4章市場動態

  • 市場促進因素
  • 市場限制因素
  • 波特五力分析
  • 產業價值鏈分析
  • 分析師觀點

第5章全球眼科超音波系統市場：依類型

  • 介紹
  • 掃描
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • B掃描
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 複合掃描
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 角膜測厚器
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 超音波生物顯微鏡（UBM）
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力

第6章眼科超音波系統的全球市場：依便攜性分類

  • 介紹
  • 可攜式眼科超音波系統
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 獨立眼科超音波系統
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力

第7章全球眼科超音波系統市場：依最終使用者分類

  • 介紹
  • 醫院
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 眼科診所
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 其他
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力

第8章全球眼科超音波系統市場：按地區

  • 介紹
  • 北美洲
    • 按類型
    • 按便攜性
    • 按最終用戶
    • 按國家/地區
  • 南美洲
    • 按類型
    • 按便攜性
    • 按最終用戶
    • 按國家/地區
  • 歐洲
    • 按類型
    • 按便攜性
    • 按最終用戶
    • 按國家/地區
  • 中東/非洲
    • 按類型
    • 按便攜性
    • 按最終用戶
    • 按國家/地區
  • 亞太地區
    • 按類型
    • 按便攜性
    • 按最終用戶
    • 按國家/地區

第9章競爭環境及分析

  • 主要企業及策略分析
  • 市場佔有率分析
  • 合併、收購、協議和合作
  • 有競爭力的儀表板

第10章 公司簡介

  • Sonomed Escalon
  • Halma plc
  • Appasamy Associates
  • DGH Technology Inc.
  • Ellex Medical Lasers Ltd
  • Quantel Medical
  • Nikon Corporation（Optos Plc）
  • NIDEK CO
  • Micro Medical Devices, Inc.
  • MEDA Co., Ltd.
簡介目錄
Product Code: KSI061611931

The Global Ophthalmic Ultrasound Systems Market is projected to grow at a CAGR of 8.16% during the forecast period to reach US$4.670 billion by 2029, from US$2.700 billion in 2022.

Ophthalmic ultrasound systems are specialized medical devices used in ophthalmology for diagnostic imaging and therapeutic purposes. These systems utilize high-frequency sound waves to create detailed images of the eye's internal structures, including the cornea, lens, vitreous humor, and retina. Ophthalmic ultrasound is particularly valuable in cases where traditional imaging techniques, such as optical coherence tomography (OCT) or fundus photography, may be insufficient due to factors like opacities in the eye's media or poor visualization of the posterior segment.

Ophthalmic ultrasound can aid in the diagnosis and management of various eye conditions, such as retinal detachment, intraocular tumors, vitreous hemorrhage, and glaucoma. Additionally, ultrasound biomicroscopy (UBM) is a specialized form of ophthalmic ultrasound used for high-resolution imaging of anterior segment structures like the iris, ciliary body, and angle. Ophthalmic ultrasound systems play a crucial role in the comprehensive evaluation and treatment of ocular diseases, contributing to improved patient care and outcomes in ophthalmology practice.

Market Drivers:

Increasing optical disorders are expected to propel the ophthalmic ultrasound systems market growth.

The increasing predominance of optical illnesses like nearsightedness, hyperopia, astigmatism, and presbyopia around the world is predicted to boost the ophthalmic ultrasound systems market expansion within the estimated period. For instance, as per the World Health Organization's data of October 2021, around 2.2 billion people globally endure close or far-off vision disability, approximately 1 billion cases being preventable or however to be tended to.

Besides, the WHO evaluated that around 826 million individuals around the world are influenced by unaddressed presbyopia. Refractive errors, age-related macular degeneration, cataracts, and glaucoma are recognized as the major causes of vision disability and visual impairment all over the world, with vision loss influencing people of different ages, though transcendently those above fifty years of age. These discoveries emphasize the expanding burden of eye illnesses universally, driving the demand for ophthalmic ultrasound devices market, which are pivotal for diagnosing such conditions.

The increasing prevalence of diabetic retinopathy is anticipated to increase the demand for ophthalmic ultrasound systems.

The prevalence of diabetic retinopathy is one of the major causes for the market expansion in the year ahead. For instance, recent data from the American Academy of Ophthalmology indicates that there are around 387 million individuals worldwide living with diabetes mellitus in the year 2016, which is expected to expand to 592 million by 2035.

Additionally, diabetic retinopathy affects approximately 93 million individuals globally. Among individuals with type 1 diabetes, the prevalence of diabetic retinopathy is 77.3%, while for those with type 2 diabetes, it is 25.1%. It is estimated that 25% to 30% of type 2 diabetes patients will develop vision-threatening diabetic macular edema. Laser therapy is required for 5% to 8% of patients with diabetic retinopathy.

North America is expected to hold a substantial portion of the market.

Variables like increasing awareness, rising disposable incomes, a developing elderly populace, and the predominance of eye conditions are growing market extensions within North America. Several research article highlights on the predominance of visual impairment and other visual disorders.

For illustration, there are around 12 million adults that are aged forty and over in the US who have vision loss that cannot be rectified, with over 1 million of them classified as blind. It is anticipated that the number of blind people will surge to 8.96 million by 2050, to a great extent due to the rising predominance of diabetes and other chronic ailments, as well as the elderly population within the United States. Besides, the Centers for Disease Control and Prevention (CDC) report that about 3% of children below the age of 18 years encounter visual impairment or blindness.

The rise in undiagnosed target diseases is additionally anticipated to contribute to market expansion.

Further, the Ontario Association of Optometrists article in July 2021 stated the effect of Canada's aging populace on the predominance of corrected vision. The report shown that 1.2 million Canadians encounter vision loss, with 466,000 dwelling in Ontario alone.

Moreover, over 8 million Canadians, about 3.1 million in Ontario, are influenced by one of the four fundamental eye illnesses (age-related macular degeneration, glaucoma, diabetic retinopathy, and cataracts), putting them at the chance of vision loss or now encountering it. The expanding predominance of eye disorders is anticipated to drive share for the ophthalmic ultrasound systems market and hence fuel industry expansion.

Market Developments:

  • April 2024- Warburg Pincus bought a stake in Appasamy Associates, India's largest ophthalmic equipment and intraocular lens manufacturer. This is the largest healthcare sector investment by the firm in India. Appasamy's strong R&D capabilities and vertical integration enable it to offer products at affordable prices.
  • February 2023- NIDEK launched the Cube a Ophthalmic Surgical System, a new ultrasound technology that enhances phacoemulsification and surgical safety. The system, designed with Gyro torsional technology, ensures efficient delivery of ultrasound energy, particularly for moderate cataracts, and protects intraocular tissues, making it a valuable addition to the ophthalmic surgical equipment range.
  • October 2022- Halma purchased IZI Medical Product for approximately EUR 138 million (equivalent to USD 145 million). This acquisition aims to enhance its footprint in various diagnostic and therapeutic procedures.
  • March 2022-Lumibird Medical opened a subsidiary in Mumbai, Lumibird Medical India, to boost sales of Quantel Medical and Ellex products in India. The subsidiary aims to provide a shared range of ultrasound platforms, ophthalmic lasers, and equipment for dry eye diagnosis and treatment.

Company Product:

  • On-platform ultrasound system XBit 90- The XBit 90 is a premium ultrasound system by CHISON Medical Technologies, featuring the latest NIT platform and advanced features such as Shear Wave Elastography, Elastography, SonoCrystal, and strain and strain ratio measurements. It offers multi-modality imaging and can be used in various fields such as OB/GYN, cardiovascular, MSK, critical care, emergency medicine, anesthesia, and pediatrics. The system offers various imaging modes, including B/W, color Doppler, 3D/4D, spectral Doppler, elastography, and needle guidance. It also offers built-in consoles and touchscreen options and can be used for various probe types.
  • Ezer Ultrasonic A/B scanner EUS-2600- The Ezer EUS-2600 Ultrasonic A/B scanner by US Ophthalmic offers multiple TGC options, real-time image/video capture, a large 12.1" LCD touchscreen display, user-friendly clinical reporting, automatic AL acquisition, PDF reports, interfaces like HDMI and DICOM 3.0 protocol, and a massive storage capacity for over 20,000 exams. It also features a high-definition 20MHz B-Scan probe and a Dist-5 immersion method.

Market Segmentation:

Global Ophthalmic Ultrasound Systems Market is segmented and analyzed as below:

By Type

  • A-Scan
  • B-Scan
  • Combined Scan
  • Pachymeter
  • Ultrasound Bio-microscopy (UBM)

By Portability

  • Portable Ophthalmic Ultrasound Systems
  • Standalone Ophthalmic Ultrasound Systems

By End-user

  • Hospitals
  • Ophthalmology Clinics
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits for the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. GLOBAL OPHTHALMIC ULTRASOUND SYSTEMS MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. A-Scan
    • 5.2.1. Market Opportunities and Trends
    • 5.2.2. Growth Prospects
    • 5.2.3. Geographic Lucrativeness
  • 5.3. B-Scan
    • 5.3.1. Market Opportunities and Trends
    • 5.3.2. Growth Prospects
    • 5.3.3. Geographic Lucrativeness
  • 5.4. Combined Scan
    • 5.4.1. Market Opportunities and Trends
    • 5.4.2. Growth Prospects
    • 5.4.3. Geographic Lucrativeness
  • 5.5. Pachymeter
    • 5.5.1. Market Opportunities and Trends
    • 5.5.2. Growth Prospects
    • 5.5.3. Geographic Lucrativeness
  • 5.6. Ultrasound Bio-microscopy (UBM)
    • 5.6.1. Market Opportunities and Trends
    • 5.6.2. Growth Prospects
    • 5.6.3. Geographic Lucrativeness

6. GLOBAL OPHTHALMIC ULTRASOUND SYSTEMS MARKET BY PORTABILITY

  • 6.1. Introduction
  • 6.2. Portable Ophthalmic Ultrasound Systems
    • 6.2.1. Market Opportunities and Trends
    • 6.2.2. Growth Prospects
    • 6.2.3. Geographic Lucrativeness
  • 6.3. Standalone Ophthalmic Ultrasound Systems
    • 6.3.1. Market Opportunities and Trends
    • 6.3.2. Growth Prospects
    • 6.3.3. Geographic Lucrativeness

7. GLOBAL OPHTHALMIC ULTRASOUND SYSTEMS MARKET BY END-USERS

  • 7.1. Introduction
  • 7.2. Hospitals
    • 7.2.1. Market Opportunities and Trends
    • 7.2.2. Growth Prospects
    • 7.2.3. Geographic Lucrativeness
  • 7.3. Ophthalmology Clinics
    • 7.3.1. Market Opportunities and Trends
    • 7.3.2. Growth Prospects
    • 7.3.3. Geographic Lucrativeness
  • 7.4. Others
    • 7.4.1. Market Opportunities and Trends
    • 7.4.2. Growth Prospects
    • 7.4.3. Geographic Lucrativeness

8. GLOBAL OPHTHALMIC ULTRASOUND SYSTEMS MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Type
    • 8.2.2. By Portability
    • 8.2.3. By End-Users
    • 8.2.4. By Country
      • 8.2.4.1. USA
        • 8.2.4.1.1. Market Opportunities and Trends
        • 8.2.4.1.2. Growth Prospects
      • 8.2.4.2. Canada
        • 8.2.4.2.1. Market Opportunities and Trends
        • 8.2.4.2.2. Growth Prospects
      • 8.2.4.3. Mexico
        • 8.2.4.3.1. Market Opportunities and Trends
        • 8.2.4.3.2. Growth Prospects
  • 8.3. South America
    • 8.3.1. By Type
    • 8.3.2. By Portability
    • 8.3.3. By End-Users
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
        • 8.3.4.1.1. Market Opportunities and Trends
        • 8.3.4.1.2. Growth Prospects
      • 8.3.4.2. Argentina
        • 8.3.4.2.1. Market Opportunities and Trends
        • 8.3.4.2.2. Growth Prospects
      • 8.3.4.3. Others
        • 8.3.4.3.1. Market Opportunities and Trends
        • 8.3.4.3.2. Growth Prospects
  • 8.4. Europe
    • 8.4.1. By Type
    • 8.4.2. By Portability
    • 8.4.3. By End-Users
    • 8.4.4. By Country
      • 8.4.4.1. United Kingdom
        • 8.4.4.1.1. Market Opportunities and Trends
        • 8.4.4.1.2. Growth Prospects
      • 8.4.4.2. Germany
        • 8.4.4.2.1. Market Opportunities and Trends
        • 8.4.4.2.2. Growth Prospects
      • 8.4.4.3. France
        • 8.4.4.3.1. Market Opportunities and Trends
        • 8.4.4.3.2. Growth Prospects
      • 8.4.4.4. Spain
        • 8.4.4.4.1. Market Opportunities and Trends
        • 8.4.4.4.2. Growth Prospects
      • 8.4.4.5. Others
        • 8.4.4.5.1. Market Opportunities and Trends
        • 8.4.4.5.2. Growth Prospects
  • 8.5. Middle East and Africa
    • 8.5.1. By Type
    • 8.5.2. By Portability
    • 8.5.3. By End-Users
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
        • 8.5.4.1.1. Market Opportunities and Trends
        • 8.5.4.1.2. Growth Prospects
      • 8.5.4.2. UAE
        • 8.5.4.2.1. Market Opportunities and Trends
        • 8.5.4.2.2. Growth Prospects
      • 8.5.4.3. Israel
        • 8.5.4.3.1. Market Opportunities and Trends
        • 8.5.4.3.2. Growth Prospects
      • 8.5.4.4. Others
        • 8.5.4.4.1. Market Opportunities and Trends
        • 8.5.4.4.2. Growth Prospects
  • 8.6. Asia Pacific
    • 8.6.1. By Type
    • 8.6.2. By Portability
    • 8.6.3. By End-Users
    • 8.6.4. By Country
      • 8.6.4.1. China
        • 8.6.4.1.1. Market Opportunities and Trends
        • 8.6.4.1.2. Growth Prospects
      • 8.6.4.2. Japan
        • 8.6.4.2.1. Market Opportunities and Trends
        • 8.6.4.2.2. Growth Prospects
      • 8.6.4.3. India
        • 8.6.4.3.1. Market Opportunities and Trends
        • 8.6.4.3.2. Growth Prospects
      • 8.6.4.4. South Korea
        • 8.6.4.4.1. Market Opportunities and Trends
        • 8.6.4.4.2. Growth Prospects
      • 8.6.4.5. Others
        • 8.6.4.5.1. Market Opportunities and Trends
        • 8.6.4.5.2. Growth Prospects

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Sonomed Escalon
  • 10.2. Halma plc
  • 10.3. Appasamy Associates
  • 10.4. DGH Technology Inc.
  • 10.5. Ellex Medical Lasers Ltd
  • 10.6. Quantel Medical
  • 10.7. Nikon Corporation (Optos Plc)
  • 10.8. NIDEK CO
  • 10.9. Micro Medical Devices, Inc.
  • 10.10. MEDA Co., Ltd.